- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07434830
Multidimensional Predictors of Balance in Healthy Young Adults
February 25, 2026 updated by: Hatice Gül, Akdeniz University
Determinants of Static and Dynamic Balance in Healthy Young Adults: A Multidimensional Observational Study
Brief Summary (for ClinicalTrials.gov)
This cross-sectional observational study aims to identify independent determinants of static and dynamic balance in healthy young adults using a multidimensional assessment framework.
A total of 119 healthy participants (mean age 22.6 ± 1.5 years; 61.3% female) completed standardized static balance tests (Stork Balance Test and Tandem Stance Test under eyes-open and eyes-closed conditions) and a dynamic balance test (Y-Balance Test for right and left limbs).
Candidate explanatory factors include foot posture (Foot Posture Index-6), body composition assessed by bioelectrical impedance analysis, general muscle strength (dominant hand grip strength), weight-bearing ankle dorsiflexion range of motion (knee-to-wall/weight-bearing lunge test), functional lower-limb strength (30-second sit-to-stand test), sex, and cognitive performance (Stroop Test Part 5).
Multiple linear regression model (enter method) was used to determine which factors independently predict static and dynamic balance outcomes.
Findings are expected to clarify which structural, functional, and cognitive variables most strongly contribute to balance performance in healthy young adults, informing targeted assessment and prevention strategies.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
119
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Konyaaltı
-
Antalya, Konyaaltı, Turkey (Türkiye), 07070
- Pamukkale University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The study population consists of 119 healthy young adults who were voluntarily enrolled (mean age 22.6 ± 1.5 years; 61.3% female).
Description
Inclusion Criteria:
- age 18-30 years
- absence of lower extremity
- absence of vestibular pathology
- willingness to participate.
Exclusion Criteria:
- neurological or neuromuscular disorders
- leg length discrepancy >5 mm
- visual or auditory impairment
- history of middle ear infection in the last 6 months
- recent (<6 months) lower extremity injury
- Having a fracture
- Having surgery
- Having tinnitus
- Having a persistent headache
- Current use of medications that may influence balance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy participants
|
Participants completed standardized static balance tests (Stork Balance Test and Tandem Stance Test under eyes-open and eyes-closed conditions) and dynamic balance assessments using the Y-Balance Test for both right and left limbs.
In addition, the following measurements were obtained: foot posture (Foot Posture Index-6), body composition via bioelectrical impedance analysis, general muscle strength (dominant hand grip strength), weight-bearing ankle dorsiflexion range of motion (knee-to-wall/weight-bearing lunge test), functional lower-limb strength (30-second sit-to-stand test), sex, and cognitive performance (Stroop Test Part 5).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stork Balance Test (Eyes Open and Eyes Closed) Time
Time Frame: At a single study visit (baseline)
|
Time (seconds) maintained in the Stork Balance Test under eyes-open and eyes-closed conditions.
Higher values indicate better static balance.
|
At a single study visit (baseline)
|
|
Tandem Stance Test (Eyes Open and Eyes Closed) Time
Time Frame: At a single study visit (baseline)
|
Time (seconds) maintained in the Tandem Stance Test under eyes-open and eyes-closed conditions.
Higher values indicate better static balance.
|
At a single study visit (baseline)
|
|
Y-Balance Test Composite Score (Right and Left)
Time Frame: At a single study visit (baseline)
|
Y-Balance Test composite score (%) for the right and left lower limbs, calculated from reach distances and normalized to limb length.
Higher values indicate better dynamic balance.
|
At a single study visit (baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Foot Posture Index-6 (FPI-6)
Time Frame: Baseline (single assessment session)
|
Foot posture assessed using the Foot Posture Index-6.
Outcome: total FPI-6 score (-12 to +12), with higher scores indicating a more pronated foot posture.
|
Baseline (single assessment session)
|
|
Knee-to-Wall Test (KTW)
Time Frame: Baseline (single assessment session)
|
Ankle mobility was assessed with the Knee-to-Wall Test (KTW).
In this test, functional dorsiflexion flexibility was measured using a tape measure placed on the tip of the foot while the participant attempted to touch the wall with the knee without heel lift.
|
Baseline (single assessment session)
|
|
30-Second Sit-to-Stand Test
Time Frame: Baseline (single assessment session)
|
Number of full sit-to-stand repetitions completed in 30 seconds.
Higher counts indicate better functional lower-limb strength/endurance.
|
Baseline (single assessment session)
|
|
Dominant Hand Grip Strength
Time Frame: Baseline (single assessment session)
|
General muscle strength was assessed via dominant hand grip strength measurement.
Dominant hand grip strength measured using a hand dynamometer.
Outcome: mean grip strength (kg) across three trials.
Higher values indicate greater general muscle strength.
|
Baseline (single assessment session)
|
|
Stroop Test
Time Frame: Baseline (single assessment session)
|
Cognitive performance was tested with the Stroop Test-Part 5.
In this section, participants were required to name the ink color of incongruent color words rather than reading the words.
Completion time was recorded with a stopwatch.
|
Baseline (single assessment session)
|
|
Fat Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
|
Fat mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
|
Baseline (single assessment session)
|
|
Skeletal Muscle Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
|
Skeletal muscle mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
|
Baseline (single assessment session)
|
|
Bone Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
|
Bone mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
|
Baseline (single assessment session)
|
|
Total Body Water (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
|
Total body water is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
|
Baseline (single assessment session)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2025
Primary Completion (Actual)
January 10, 2026
Study Completion (Actual)
January 10, 2026
Study Registration Dates
First Submitted
February 17, 2026
First Submitted That Met QC Criteria
February 22, 2026
First Posted (Actual)
February 27, 2026
Study Record Updates
Last Update Posted (Actual)
February 27, 2026
Last Update Submitted That Met QC Criteria
February 25, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 09.09.2025/17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adult
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Applied Food Sciences Inc.The Center for Applied Health Sciences, LLCCompletedHealthy Adult Females | Healthy Adult MaleUnited States
-
Applied Food Sciences Inc.Alethios, Inc.RecruitingHealthy Adult Females | Joint Discomfort | Healthy Adult MaleUnited States
-
University Hospital, Strasbourg, FranceICube LaboratoryNot yet recruitingHealthy | Healthy AdultFrance
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
Mohamad KaramCompleted
-
GH Research Ireland LimitedNot yet recruitingHealthy AdultUnited States
Clinical Trials on Participants did not receive any intervention as part of the study; they only underwent assessments.
-
Assiut UniversityNot yet recruitingPhiladelphia Negative Myeloproliferative Neoplasms
-
The HIV Netherlands Australia Thailand Research...Taksin HospitalCompleted
-
Fundación Investigación E Innovación Biomédica...Recruiting
-
Shanghai Zhongshan HospitalRecruiting
-
Gazi UniversityGazi University Scientific Research UnitCompletedObesity | PeriodontitisTurkey
-
NeuroOne Medical Technologies CorporationNot yet recruitingDrug Resistant Epilepsy | Refractory Epilepsy
-
Karolinska InstitutetKarolinska University HospitalCompletedEpilepsy | Ischemic Stroke | Traumatic Brain Injury | Meningitis | Stroke, Acute | Subarachnoid Hemorrhage, Aneurysmal | Intracerebral Hemorrhage | Acute Brain Injuries | Acute Neurological Injury | Neuro-intensive Care Unit PatientsSweden
-
The Hong Kong Polytechnic UniversityRecruitingOlder Adults | Cognitive Decline | Brain Imaging | Chronic Non-Specific Low Back Pain | Cross-Sectional StudyHong Kong
-
The First Affiliated Hospital of Xinxiang Medical...Not yet recruiting